In neuroblastoma, two BDP1 variants were identified to be associated with poor clinical outcomes36 and recently, BDP1 expression has been correlated with clinical outcomes in non‐Hodgkin lymphoma (NHL)35 and breast cancer.34 The gene discussed is BDP1; the disease is breast cancer.